vs

Side-by-side financial comparison of INTERGROUP CORP (INTG) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $17.3M, roughly 1.3× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -165.4%, a 174.2% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -25.3%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-65.0M). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs 0.4%).

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

INTG vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.3× larger
NKTR
$21.8M
$17.3M
INTG
Growing faster (revenue YoY)
INTG
INTG
+45.1% gap
INTG
19.8%
-25.3%
NKTR
Higher net margin
INTG
INTG
174.2% more per $
INTG
8.8%
-165.4%
NKTR
More free cash flow
INTG
INTG
$64.5M more FCF
INTG
$-481.0K
$-65.0M
NKTR
Faster 2-yr revenue CAGR
INTG
INTG
Annualised
INTG
7.8%
0.4%
NKTR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
INTG
INTG
NKTR
NKTR
Revenue
$17.3M
$21.8M
Net Profit
$1.5M
$-36.1M
Gross Margin
Operating Margin
11.6%
-126.9%
Net Margin
8.8%
-165.4%
Revenue YoY
19.8%
-25.3%
Net Profit YoY
155.6%
-596.9%
EPS (diluted)
$0.71
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTG
INTG
NKTR
NKTR
Q4 25
$17.3M
$21.8M
Q3 25
$17.9M
$11.8M
Q2 25
$16.2M
$11.2M
Q1 25
$16.8M
$10.5M
Q4 24
$14.4M
$29.2M
Q3 24
$16.9M
$24.1M
Q2 24
$13.4M
$23.5M
Q1 24
$14.9M
$21.6M
Net Profit
INTG
INTG
NKTR
NKTR
Q4 25
$1.5M
$-36.1M
Q3 25
$-535.0K
$-35.5M
Q2 25
$-2.2M
$-41.6M
Q1 25
$-578.0K
$-50.9M
Q4 24
$-2.7M
$7.3M
Q3 24
$-398.0K
$-37.1M
Q2 24
$-4.9M
$-52.4M
Q1 24
$-3.2M
$-36.8M
Gross Margin
INTG
INTG
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
INTG
INTG
NKTR
NKTR
Q4 25
11.6%
-126.9%
Q3 25
15.3%
-268.6%
Q2 25
8.1%
-324.2%
Q1 25
14.0%
-425.8%
Q4 24
5.9%
49.2%
Q3 24
18.5%
-142.4%
Q2 24
3.7%
-211.9%
Q1 24
4.8%
-163.7%
Net Margin
INTG
INTG
NKTR
NKTR
Q4 25
8.8%
-165.4%
Q3 25
-3.0%
-301.3%
Q2 25
-13.9%
-372.2%
Q1 25
-3.4%
-486.4%
Q4 24
-18.9%
24.9%
Q3 24
-2.4%
-153.6%
Q2 24
-36.7%
-222.9%
Q1 24
-21.3%
-170.1%
EPS (diluted)
INTG
INTG
NKTR
NKTR
Q4 25
$0.71
$-4.67
Q3 25
$-0.25
$-1.87
Q2 25
$-2.95
Q1 25
$-0.27
$-0.24
Q4 24
$-1.26
$-2.07
Q3 24
$-0.18
$-2.66
Q2 24
$-3.76
Q1 24
$-1.44
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTG
INTG
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$7.5M
$15.1M
Total DebtLower is stronger
$233.2M
Stockholders' EquityBook value
$-85.2M
$89.8M
Total Assets
$101.1M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTG
INTG
NKTR
NKTR
Q4 25
$7.5M
$15.1M
Q3 25
$6.0M
$41.0M
Q2 25
$6.1M
$43.0M
Q1 25
$4.8M
$38.9M
Q4 24
$15.4M
$44.3M
Q3 24
$12.2M
$30.1M
Q2 24
$11.6M
$27.9M
Q1 24
$19.5M
$48.6M
Total Debt
INTG
INTG
NKTR
NKTR
Q4 25
$233.2M
Q3 25
$237.8M
Q2 25
$240.5M
Q1 25
$241.5M
Q4 24
$227.2M
Q3 24
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
INTG
INTG
NKTR
NKTR
Q4 25
$-85.2M
$89.8M
Q3 25
$-86.7M
$85.1M
Q2 25
$-86.1M
$-24.2M
Q1 25
$-84.5M
$13.7M
Q4 24
$-83.9M
$60.7M
Q3 24
$-80.9M
$48.9M
Q2 24
$-80.3M
$79.7M
Q1 24
$-76.4M
$126.7M
Total Assets
INTG
INTG
NKTR
NKTR
Q4 25
$101.1M
$280.4M
Q3 25
$102.5M
$301.3M
Q2 25
$104.1M
$207.5M
Q1 25
$103.2M
$256.2M
Q4 24
$110.6M
$303.9M
Q3 24
$109.3M
$308.0M
Q2 24
$107.8M
$343.3M
Q1 24
$119.0M
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTG
INTG
NKTR
NKTR
Operating Cash FlowLast quarter
$-23.0K
$-65.0M
Free Cash FlowOCF − Capex
$-481.0K
$-65.0M
FCF MarginFCF / Revenue
-2.8%
-298.0%
Capex IntensityCapex / Revenue
2.6%
0.1%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$739.0K
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTG
INTG
NKTR
NKTR
Q4 25
$-23.0K
$-65.0M
Q3 25
$-296.0K
$-48.8M
Q2 25
$5.9M
$-45.7M
Q1 25
$-854.0K
$-49.1M
Q4 24
$-781.0K
$-46.2M
Q3 24
$3.4M
$-43.9M
Q2 24
$6.8M
$-37.7M
Q1 24
$1.9M
$-47.9M
Free Cash Flow
INTG
INTG
NKTR
NKTR
Q4 25
$-481.0K
$-65.0M
Q3 25
$-1.3M
$-48.9M
Q2 25
$3.6M
$-45.8M
Q1 25
$-1.2M
$-49.1M
Q4 24
$-1.1M
$-46.6M
Q3 24
$3.1M
$-44.6M
Q2 24
$2.7M
$-37.9M
Q1 24
$1.1M
$-48.0M
FCF Margin
INTG
INTG
NKTR
NKTR
Q4 25
-2.8%
-298.0%
Q3 25
-7.1%
-414.5%
Q2 25
22.5%
-409.6%
Q1 25
-6.8%
-469.0%
Q4 24
-7.8%
-159.9%
Q3 24
18.3%
-184.9%
Q2 24
20.4%
-161.3%
Q1 24
7.6%
-222.0%
Capex Intensity
INTG
INTG
NKTR
NKTR
Q4 25
2.6%
0.1%
Q3 25
5.4%
1.0%
Q2 25
13.9%
0.3%
Q1 25
1.8%
0.0%
Q4 24
2.4%
1.6%
Q3 24
1.6%
2.8%
Q2 24
30.4%
0.8%
Q1 24
4.9%
0.7%
Cash Conversion
INTG
INTG
NKTR
NKTR
Q4 25
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

NKTR
NKTR

Segment breakdown not available.

Related Comparisons